Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial

References

• UNODCWorld Drug ReportVienna, AustriaUnited Nations2008
   Google Scholar
• AnthonyJCWarnerLAKesslerRCComparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the National Comorbidity SurveyExp Clin Psychopharmacol19942244268
   Web of Science ®Google Scholar
• CopelandJSwiftWCannabis use disorder: epidemiology and managementInt Rev Psychiatry20092129610319367503
   PubMed Web of Science ®Google Scholar
• BudneyAJMooreBAVandreyRGHughesJRThe time course and significance of cannabis withdrawalJ Abnorm Psychol2003112339340212943018
   PubMed Web of Science ®Google Scholar
• StephensRSRoffmanRACurtinLComparison of extended versus brief treatments for marijuana useJ Consult Clin Psychol200068589890811068976
   PubMed Web of Science ®Google Scholar
• ChungTMartinCSCorneliusJRClarkDBCannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescentsAddiction2008103578779918412757
   PubMed Web of Science ®Google Scholar
• LevinKHCopersinoMLHeishmanSJCannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokersDrug Alcohol Depend20101111–212012720510550
   PubMed Web of Science ®Google Scholar
• HartCLIncreasing treatment options for cannabis dependence: a review of potential pharmacotherapiesDrug Alcohol Depend200580214715915899556
   PubMed Web of Science ®Google Scholar
• HaneyMHartCLVosburgSKMarijuana withdrawal in humans: effects of oral THC or divalproexNeuropsychopharmacology200429115817014560320
   PubMed Web of Science ®Google Scholar
• WinstockARLeaTCopelandJLithium carbonate in the management of cannabis withdrawal in humans: an open-label studyJ Psychopharmacol2009231849318515451
   PubMed Web of Science ®Google Scholar
• HaneyMHartCLWardASFoltinRWNefazodone decreases anxiety during marijuana withdrawal in humansPsychopharmacology (Berl)2003165215716512439626
   PubMed Web of Science ®Google Scholar
• HaneyMWardASComerSDHartCLFoltinRWFischmanMWBupropion SR worsens mood during marijuana withdrawal in humansPsychopharmacology (Berl)2001155217117911401006
   PubMed Web of Science ®Google Scholar
• BudneyAJVandreyRGHughesJRMooreBABahrenburgBOral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptomsDrug Alcohol Depend2007861222916769180
   PubMed Web of Science ®Google Scholar
• LevinFRMarianiJJBrooksDJPavlicovaMChengWNunesEVDronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trialDrug Alcohol Depend20111161–314215021310551
   PubMed Web of Science ®Google Scholar
• HaneyMHartCLVosburgSKComerSDReedSCFoltinRWEffects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapsePsychopharmacology (Berl)2008197115716818161012
   PubMed Web of Science ®Google Scholar
• MauriMCVolonteriLSFiorentiniAPirolaRBareggiSRTwo weeks’ quetiapine treatment for schizophrenia, drug-induced p sychosis and borderline personality disorder: a naturalistic study with drug plasma levelsExpert Opin Pharmacother20078142207221317927477
   PubMed Web of Science ®Google Scholar
• WestRGossopMOverview: a comparison of withdrawal symptoms from different drug classesAddiction19948911148314897841860
   PubMed Web of Science ®Google Scholar
• BressanRACrippaJAThe role of dopamine in reward and pleasure behaviour – review of data from preclinical researchActa Psychiatr Scand Suppl2005427142115877719
   PubMedGoogle Scholar
• ZhornitskySRizkallahEPampoulovaTAntipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosisJ Clin Psychopharmacol201030441742420631559
   PubMed Web of Science ®Google Scholar
• PotvinSStipERoyJYThe effect of quetiapine on cannabis use in 8 psychosis patients with drug dependencyCan J Psychiatry2004491071115560324
   PubMed Web of Science ®Google Scholar
• RizkallahEStipEZhornitskySClinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trialExpert Opin Pharmacother201011182947295120979569
   PubMed Web of Science ®Google Scholar
• sanofi-aventisNeulactil Data Sheet8222011 Available from: www.sanofi-aventis.com.au/products/nzl_ds_neulactil.pdfAccessed on February 13, 2012
   Google Scholar
• GossopMDarkeSGriffithsPThe Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine usersAddiction19959056076147795497
   PubMed Web of Science ®Google Scholar
• BastienCHVallieresAMorinCMValidation of the Insomnia Severity Index as an outcome measure for insomnia researchSleep Med20012429730711438246
   PubMed Web of Science ®Google Scholar
• LovibondPLovibondSThe structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety InventoriesBehav Res Ther19953333353437726811
   PubMed Web of Science ®Google Scholar
• SwiftWCopelandJHallWChoosing a diagnostic cut-off for cannabis dependenceAddiction19989311168116929926531
   PubMed Web of Science ®Google Scholar
• CopelandJSwiftWRoffmanRStephensRA randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorderJ Subst Abuse Treat20012125564 discussion 65–5611551733
   PubMed Web of Science ®Google Scholar
• LeeKSCloughARJaragbaMJConigraveKMPattonGCHeavy cannabis use and depressive symptoms in three Aboriginal communities in Arnhem Land, Northern TerritoryMed J Aust20081881060560818484938
   PubMed Web of Science ®Google Scholar
• YangMCharlesMSchaeferKWallensteinGInterpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important differenceCurr Med Res Opin200925102487249419689221
   PubMed Web of Science ®Google Scholar
• WeinsteinAMGorelickDAPharmacological treatment of cannabis dependenceCurr Pharm Des201117141351135821524266
   PubMed Web of Science ®Google Scholar
• HaneyMThe marijuana withdrawal syndrome: diagnosis and treatmentCurr Psychiatry Rep20057536036616216154
   PubMedGoogle Scholar
• ColagiuriBMorleyKBoakesRHaberPExpectancy in doubleblind placebo-controlled trials: an example from alcohol dependencePsychother Psychosom200978316717119270472
   PubMed Web of Science ®Google Scholar